Press Releases Vext Science, Inc.

Equities

VEXT

CA9255401064

Healthcare Facilities & Services

Delayed Canadian Securities Exchange Other stock markets 15:21:19 20/01/2026 GMT			5-day change	1st Jan Change
0.2700 ^CAD	-3.57%		0.00%	+5.88%

11-20	Vext Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-20	Vext Science, Inc., Q3 2025 Earnings Call, Nov 20, 2025

Press Releases

01-02	Early Warning News Release of Jason T. Nguyen	NE
12-11	Vext Announces Voting Results of Annual General Meeting	NE
11-20	CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results	NE
11-20	Vext Science : Third Quarter 2025 Press Release	PU
11-20	Vext Science : Third Quarter 2025 Financial Statements	PU
11-20	Vext Science : Third Quarter 2025 MD&A	PU
11-20	Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million	NE
11-11	Vext to Announce Financial Results for Q3 2025 on November 20, 2025	NE
21/10/25	Vext Science : Investor Presentation - October 2025	PU
17/09/25	Vext Secures State Approval for Portsmouth Dispensary Ownership Transfer	NE
28/08/25	Vext Science : Investor Presentation - August 2025	PU
20/08/25	Vext Science : Second Quarter 2025 Press Release	PU
20/08/25	Vext Science : Second Quarter 2025 Financial Statements	PU
20/08/25	Vext Science : Second Quarter 2025 MD&A	PU
20/08/25	Vext Announces Q2 2025 Financial Results: Record Quarterly Revenue with Strong 31% Cash Flow Margin	NE
11/08/25	Vext to Announce Financial Results for Q2 2025 on August 20, 2025	NE
03/07/25	Vext Science : Investor Presentation July 2025	PU
24/06/25	Vext Continues Ohio Expansion with Sixth Dispensary Location in Fairfield	NE
16/06/25	Vext Opens Fifth Ohio Dispensary in Portsmouth, Growing Retail Footprint in Key Ohio Market	NE
05/06/25	Vext Announces Change of Auditor	NE
03/06/25	Vext Science : Investor Presentation - May 2025	PU
21/05/25	Vext Science : First Quarter 2025 Press Release	PU
21/05/25	Vext Science : First Quarter 2025 MD&A	PU
21/05/25	Vext Delivers Record Q1 Performance: Achieves $3.1 Million in Operating Cash Flow on $11.6 Million in Revenue	NE
13/05/25	Vext to Announce Financial Results for Q1 2025 on May 21, 2025	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Press Releases Vext Science, Inc.

Equities

VEXT

CA9255401064

Healthcare Facilities & Services

Press Releases

Filters